MENU
+Compare
CNVVY
Stock ticker: OTC
AS OF
Jan 15 closing price
Price
$12.78
Change
-$0.05 (-0.39%)
Capitalization
6.17B

CNVVY stock forecast, quote, news & analysis

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings... Show more

CNVVY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for CNVVY with price predictions
Jan 15, 2026

CNVVY's Stochastic Oscillator descends into oversold zone

The Stochastic Oscillator for CNVVY moved into oversold territory on January 15, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

CNVVY moved above its 50-day moving average on December 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CNVVY crossed bullishly above the 50-day moving average on December 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNVVY advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 223 cases where CNVVY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNVVY as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNVVY turned negative on January 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNVVY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNVVY broke above its upper Bollinger Band on January 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.439) is normal, around the industry mean (11.729). P/E Ratio (30.142) is within average values for comparable stocks, (163.085). Projected Growth (PEG Ratio) (1.607) is also within normal values, averaging (2.570). Dividend Yield (0.021) settles around the average of (0.016) among similar stocks. P/S Ratio (2.787) is also within normal values, averaging (112.878).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNVVY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

CNVVY paid dividends on October 16, 2025

ConvaTec Group plc CNVVY Stock Dividends
А dividend of $0.07 per share was paid with a record date of October 16, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 12.06B. The market cap for tickers in the group ranges from 246 to 191.9B. ISRG holds the highest valuation in this group at 191.9B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -0%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -0%. ECIA experienced the highest price growth at 25%, while ZJYL experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 64
Price Growth Rating: 58
SMR Rating: 78
Profit Risk Rating: 93
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
CNVVY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
20 Eastbourne Terrace
Phone
+44 7826447807
Employees
10129
Web
https://www.convatecgroup.com